David T. Tse, M.D., is a thought-leader in oculoplastic surgery and orbital diseases who pioneered the use of intra-arterial neoadjuvant chemotherapy in treating a lethal lacrimal gland malignancy to improve long-term disease-free survival substantially. He founded the Nasser Al-Rashid Orbital Vision Research Center at Bascom Palmer, the first cure-based orbital research laboratory of its kind in… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Miami Miller School of Medicine | Doctorate | Other | 1976 |
| University of Southern California Medical Center (Post Graduate Training) | Other Degree | Internal Medicine | 1976 |
| Institution | Focus | Year |
|---|---|---|
| Residency - University of Southern California Medical Center | Ophthalmology | 1981 |
| Fellowship - University of Iowa Carver College of Medicine | Oculoplastic Surgery | 1982 |
| Certification | Cert. Body | Year |
|---|---|---|
| Ophthalmology | Ophthalmology | Not Specified |
Ophthalmology
Years In Practice: 42 (started in 1983)
Accepts New Patients: Yes
David T Tse, MD has not yet listed the medications that he commonly prescribes.
David T Tse, MD has not yet specified the insurance plans he accepts.
